We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+0.47%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.73B
AUM Growth
-$17.8M
Cap. Flow
+$2.5M
Cap. Flow %
0.14%
Top 10 Hldgs %
14.6%
Holding
323
New
23
Increased
120
Reduced
120
Closed
29

Top Buys

Rank Stock Value
1
NICE icon
Nice
NICE
+$19.6M
2
HCSG icon
Healthcare Services Group
HCSG
+$16.1M
3
SLAB icon
Silicon Laboratories
SLAB
+$15.7M
4
PRLB icon
Protolabs
PRLB
+$9.88M
5
DECK icon
Deckers Outdoor
DECK
+$9.57M

Sector Composition

Rank Sector Weight
1 Industrials 21.59%
2 Technology 19.03%
3 Healthcare 16.92%
4 Consumer Discretionary 12.43%
5 Financials 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWH icon
276
iShares MSCI Hong Kong ETF
EWH
$1.22B
$293K 0.02%
14,800
-500
-3% -$9.16K
NRCIB
277
DELISTED
National Research Corp Class B
NRCIB
$282K 0.02%
8,043
-124
-2% -$4.26K
WOOF
278
DELISTED
VCA Inc.
WOOF
$282K 0.02%
4,882
AAP icon
279
Advance Auto Parts
AAP
$3.49B
$275K 0.02%
1,715
TDG icon
280
TransDigm Group
TDG
$67.7B
$272K 0.02%
1,234
AUTO
281
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$270K 0.02%
15,540
-241
-2% -$4.32K
PG icon
282
Procter & Gamble
PG
$339B
$264K 0.02%
3,206
-20
-0.6% -$1.61K
SBUX icon
283
Starbucks
SBUX
$120B
$256K 0.01%
4,290
+100
+2% +$5.82K
JNP
284
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$239K 0.01%
36,094
-558
-2% -$4.11K
SMED
285
DELISTED
Sharps Compliance Corp
SMED
$237K 0.01%
43,068
-665
-2% -$4.03K
GWW icon
286
W.W. Grainger
GWW
$60.2B
$231K 0.01%
990
-326
-25% -$68.3K
EWS icon
287
iShares MSCI Singapore ETF
EWS
$1.08B
$230K 0.01%
10,576
-443
-4% -$8.74K
EWT icon
288
iShares MSCI Taiwan ETF
EWT
$10.7B
$199K 0.01%
7,180
-350
-5% -$8.89K
NRC icon
289
NRC Health Common Stock
NRC
$450M
$186K 0.01%
11,988
-185
-2% -$2.71K
VNDA icon
290
Vanda Pharmaceuticals
VNDA
$302M
$186K 0.01%
22,257
-340
-2% -$2.79K
LOV
291
DELISTED
Spark Networks SE American Depositary Shares
LOV
$176K 0.01%
79,098
-1,220
-2% -$3.9K
AGRX
292
DELISTED
Agile Therapeutics
AGRX
$158K 0.01%
13
DENN
293
DELISTED
Denny's
DENN
$132K 0.01%
12,783
-198
-2% -$1.93K
MEET
294
DELISTED
The Meet Group, Inc. Common Stock
MEET
$118K 0.01%
+41,561
New +$131K
ACTG icon
295
Acacia Research
ACTG
$470M
-190,183
Closed -$816K
ADI icon
296
Analog Devices
ADI
$190B
-4,370
Closed -$242K
BMRN icon
297
BioMarin Pharmaceuticals
BMRN
$12.4B
-2,045
Closed -$214K
CNK icon
298
Cinemark Holdings
CNK
$4.32B
-613,958
Closed -$20.5M
CSGP icon
299
CoStar Group
CSGP
$12.3B
-9,940
Closed -$205K
EXAS
300
DELISTED
Exact Sciences
EXAS
-108,046
Closed -$997K

Similar funds

Rice Hall James & Associates's Q1 2016 Portfolio in Review

As of Q1 2016, Rice Hall James & Associates held 323 positions worth $1.73B, down 1% from $1.75B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates's Q1 2016 filing shows 23 new, 120 increased, 120 reduced and 29 closed positions. Its largest new stake was Nice: 327,313 shares worth $21.2M. The largest sale was Cinemark Holdings, an estimated $20.5M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

  • Rice Hall James & Associates's largest Q1 2016 buy was Nice: 327,313 shares worth $21.2M.
  • Rice Hall James & Associates added most to Electronics for Imaging in Q1 2016, an estimated $9.25M increase.
  • Rice Hall James & Associates's biggest Q1 2016 reduction was E.W. Scripps, cutting an estimated $9.46M.
  • Rice Hall James & Associates fully exited Cinemark Holdings in Q1 2016, selling an estimated $20.5M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $1.73B portfolio in Q1 2016.
  • Rice Hall James & Associates opened 23 new positions and closed 29 in Q1 2016.
  • Rice Hall James & Associates's portfolio value fell 1% quarter-over-quarter to $1.73B.

Based on Rice Hall James & Associates's 13F filing for Q1 2016, filed 26 Apr 2016.